TrialFind
Saved trials
Back to results
Completed
Phase 4
Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes
NCT01605773
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Novo Nordisk Investigational Site
Houston, Texas, United States
View on ClinicalTrials.gov
Official details
Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes — TrialFind